High Throughput Genomics
(HTG) is supplementing its service capabilities through a supply agreement with Roche
Nimblegen. The firm will provide HTG with high density, multiplex DNA microarray slides for advanced gene-expression analysis.
HTG will apply its quantitative nuclease protection assay (qNPA) process to the microarrays to enable researchers to quickly and efficiently measure the gene-expression levels in a variety of sample types. Sample preparation using qNPA technology allows for a simpler, more cost-effective workflow versus traditional labeling methods, according to HTG. The Roche NimbleGen multiplex technology offers a cost-effective high-density microarray providing in-depth gene-expression information, the company adds.